Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) could upregulate the percentage of NK cells in TIME when used in combination with CDK inhibitor in NSCLC mouse models [59]. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.